secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0000950170-23-060505
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q3 revenue up 21% to $262.9M, net loss widens to $61.6M, raises FY guidance midpoints
--------------------------------------------------------------------------------

- Revenue $262.9M (+21% YoY); clinicians up 18% to 6,418 with record organic recruiting.
- Net loss $61.6M vs $37.9M, driven by class action settlement and stock-based comp.
- Adjusted EBITDA $14.6M (5.6% of revenue) vs $15.4M (7.1%) last year.
- Raising FY 2023 guidance: revenue $1.03-1.04B, Center Margin $292-300M, Adjusted EBITDA $56-60M.
- Q4 2023 outlook: revenue $255-265M, Center Margin $73-81M, Adjusted EBITDA $17-21M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017023060505/0000950170-23-060505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017023060505/lfst-20231108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-060505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer